Back

How safe are new oral anticoagulants without bridging in comparison with phenprocoumon for patients undergoing pulmonary vein isolation?

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Ersan Akkaya

Kerckhoff-Clinic, Nauheim (Germany)

20 More presentations in this session

Presentation thumbnail
Doctor E. Ueno (Kahoku, JP)
Abstract
Presentation thumbnail
Ms G. Stynes (Uxbridge, GB)
Abstract Slides
Presentation thumbnail
Professor G. Lip (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Ms G. Stynes (Uxbridge, GB)
Abstract Slides
Presentation thumbnail
Doctor M. Rohla (Bern, CH)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of efficacy of different anticoagulation strategies used during pulmonary vein isolation in left atrial blood samples
1 September 2019
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022
thumbnail
Congress Presentation
Perioperative management of antithrombotic therapy.
29 August 2022
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources